Please login to the form below

Not currently logged in
Email:
Password:

Storm Therapeutics

This page shows the latest Storm Therapeutics news and features for those working in and with pharma, biotech and healthcare.

RNA-focused biotech Storm Therapeutics raises extra £14m

RNA-focused biotech Storm Therapeutics raises extra £14m

New head of translational oncology also hired. Storm Therapeutics, the UK-based biotech specialising in modulating RNA modifying enzymes has announced that it has raised an extra £14m ($17.8m) from ... Keith Blundy. Dr Keith Blundy, chief executive of

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Latest appointments

  • Professor Thomas Cech joins Storm Therapeutics Professor Thomas Cech joins Storm Therapeutics

    He takes up a scientific advisor role at the group. Storm Therapeutics, a company focused on the discovery of small molecule therapies has appointed Professor Thomas Cech as its scientific advisor. ... Commenting on the new appointments, Keith Blundy,

  • Storm Therapeutics bolsters its team Storm Therapeutics bolsters its team

    UK-based drug discovery group Storm Therapeutics has strengthened its scientific advisory board with the addition of Professor Mark Dawson. ... Keith Blundy, chief executive officer of Storm Therapeutics, said: “Mark’s expertise in epigenetics

  • Storm Therapeutics strengthens its board Storm Therapeutics strengthens its board

    Professor Paul Workman joins as an independent director. Drug discovery group Storm Therapeutics has appointed Professor Paul Workman to join its board. ... UK. Keith Blundy, CEO, Storm Therapeutics, said: “I am pleased to welcome Paul as indepdent

More from appointments
Approximately 3 fully matching, plus 0 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Market Access Transformation

Market Access Transformation (MAT), founded by industry veterans Baiju Aurora and Paul Howard, specializes in developing cutting edge technologies that...

Latest intelligence

Guide
How to embrace behavioural science principles in healthcare MR...
Top 10 ways to leverage the Impetus InSite Platform® to (virtually) launch your brand
The Impetus InSite Platform® can be used to facilitate virtual and hybrid engagement at all stages of the product lifecycle. Here, we share 10 of the most popular ways to...
Employee wellbeing in creative agencies: three tips to get you started
Paul Hutchings, founder of fox&cat, and new friend, Welfy, a workplace wellbeing training firm, discuss the importance of collaboration...